클로닝 및 돌연변이 유발 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Cloning And Mutagenesis Market size is expected to reach USD 25.21 Billion in 2034 from USD 5.19 Billion (2025) growing at a CAGR of 19.21% during 2026-2034.

The Global Cloning and Mutagenesis Market is witnessing steady growth due to rising research activities in molecular biology, genetics, and biotechnology. Academic institutions, pharmaceutical companies, and contract research organizations are increasingly investing in gene editing and recombinant DNA technologies. The expansion of genomics research and personalized medicine has further strengthened demand for cloning kits, enzymes, and mutagenesis tools across research laboratories worldwide.

Key growth drivers include advancements in CRISPR-based gene editing, increased funding for life science research, and the rapid development of biopharmaceuticals. Researchers are using cloning and mutagenesis techniques to understand gene function, create disease models, and develop targeted therapies. The growing prevalence of genetic disorders and cancer has accelerated the need for innovative molecular tools that can support drug discovery and therapeutic development.

Looking ahead, the market is expected to benefit from automation in laboratory workflows and improved high-throughput screening technologies. Emerging economies are expanding their research infrastructure, which will create new growth opportunities. Continuous innovation in synthetic biology and precision medicine is likely to further drive demand, positioning cloning and mutagenesis technologies as essential components of future biomedical research and therapeutic breakthroughs.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Cloning Kits
• Mutagenesis Kits

By Technology

• TOPO PCR Cloning
• Site-directed Mutagenesis

By End Use

• Biopharmaceuticals and Pharmaceutical Companies
• CROs and CMOs

COMPANIES PROFILED

• Agilent Technologies Inc, Thermo Fisher Scientific Inc, New England Biolabs, Takara Bio Inc, Merck KGaA, Promega Corporation, BioRad Laboratories Inc, Danaher, Jena Bioscience GmbH, Assay Genie, TransGen Biotech Co Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CLONING AND MUTAGENESIS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Cloning Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Mutagenesis Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CLONING AND MUTAGENESIS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. TOPO PCR Cloning Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Site-directed Mutagenesis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CLONING AND MUTAGENESIS MARKET: BY END USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End Use
• 6.2. Biopharmaceuticals and Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. CROs and CMOs Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CLONING AND MUTAGENESIS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Technology
  • 7.2.3 By End Use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Technology
  • 7.3.3 By End Use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Technology
  • 7.4.3 By End Use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Technology
  • 7.5.3 By End Use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Technology
  • 7.6.3 By End Use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CLONING AND MUTAGENESIS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Agilent Technologies Inc
  • 9.2.2 Thermo Fisher Scientific Inc
  • 9.2.3 New England Biolabs
  • 9.2.4 Takara Bio Inc
  • 9.2.5 Merck KGaA
  • 9.2.6 Promega Corporation
  • 9.2.7 Bio-Rad Laboratories Inc
  • 9.2.8 Danaher
  • 9.2.9 Jena Bioscience GmbH
  • 9.2.10 Assay Genie
  • 9.2.11 TransGen Biotech Co. Ltd